arrow
M

Martin Mynarek

University of Hamburg
H指数:31
被引数:4,503

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registries

基于前瞻性试验E-HIT2000及后续登记研究的儿童颅内室管膜瘤高级风险分层模型开发

2025-09-300
PRE
One-year follow-up of the new European reference network for pediatric cancers (ERN PaedCan) tumor board for pediatric CNS tumors: lessons learnt and future prospects

新欧洲儿科肿瘤参考网络(ERN PaedCan)儿科中枢神经系统肿瘤肿瘤委员会的一年随访:经验教训与未来展望

2025-09-160
OA
Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling

通过转录组分析,在zfta-rela融合幕上室上膜瘤中由双糖链蛋白聚糖驱动的风险分层

2025-01-070
OAAI
Impact of molecular classification on prognosis in children and adolescents with spinal ependymoma: Results from the HIT-MED database

分子分类对儿童和青少年脊髓室管膜瘤预后的影响: 来自HIT-MED数据库的结果

2024-10-230
OAAI
Distinct relapse pattern across molecular ependymoma types

跨分子室管膜瘤类型的不同复发模式

2024-08-220
PRE
SNO-EANO-EURACAN consensus on management of pineal parenchymal tumors

Sno-eano-euracan松果体实质肿瘤管理共识

2024-07-290
OA
Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level

髓母细胞瘤的多组分析揭示了蛋白质组和N-聚糖水平的亚型特异性靶向改变

2024-07-241
OAAI
Medulloblastoma in children with Fanconi anemia: Association with FA-D1/FA-N, SHH type and poor survival independent of treatment strategies

范可尼贫血患儿的髓母细胞瘤: 与FA-D1/fa-n,SHH类型和不良生存无关的治疗策略的关联

2024-06-260
PRE
MOLECULAR PATHOLOGY, TREATMENT AND PROGNOSIS OF INFANT SONIC HEDGEHOG MEDULLOBLASTOMA: A GLOBAL MULTI-COHORT STUDY

婴儿声波刺猬髓母细胞瘤的分子病理学,治疗和预后: 一项全球多队列研究

2024-06-180
OAAI
NEUROPSYCHOLOGICAL FUNCTIONING AND QUALITY OF LIFE IN INFANT AT/RT SURVIVORS: FOCUS ON FLUID INTELLIGENCE AND VISUAL PROCESSING

婴儿AT/RT幸存者的神经心理功能和生活质量: 关注流体智力和视觉处理

2024-06-180
OAAI
CAUSES AND LONG-TERM COURSE OF OTOTOXICITY IN PEDIATRIC MEDULLOBLASTOMA AND EPENDYMOMA PATIENTS - CUMULATIVE PLATINUM AND COCHLEAR IRRADIATION DOSE MATTER

小儿髓母细胞瘤和室管膜瘤患者耳毒性的原因和长期过程-累积铂和耳蜗照射剂量物质

2024-06-180
OAAI
WNT AND GROUP 4 MEDULLOBLASTOMAS OF EARLY CHILDHOOD TREATED WITH HIGH DOSE CHEMOTHERAPY AND CRANIOSPINAL IRRADIATION SPARING APPROACH

WNT和儿童早期的第4组髓母细胞瘤,采用大剂量化疗和颅骨脊髓照射保留方法治疗

2024-06-180
OAAI
IMPACT OF MOLECULAR SUBTYPING ON PROGNOSIS IN CHILDREN AND ADOLESCENTS WITH SPINAL EPENDYMOMA

分子分型对儿童和青少年脊髓室管膜瘤预后的影响

2024-06-180
OAAI
MOLECULAR MARKERS AND PREDICTORS OF OUTCOME FOR PAEDIATRIC INTRACRANIAL EPENDYMOMA IN THE PROSPECTIVE, MULTICENTRE E-HIT2000 TRIAL AND SUBSEQUENT HIT-REGISTRIES: A POOLED ANALYSIS OF 244 PATIENTS

在前瞻性,多中心E-HIT2000试验和随后的HIT注册研究中,儿童颅内室管膜瘤的分子标志物和预后预测因素: 对244例患者的汇总分析

2024-06-180
OAAI
DISTINCT RELAPSE PATTERN ACROSS MOLECULAR EPENDYMOMA TYPES

跨分子室管膜瘤类型的不同复发模式

2024-06-180
OAAI